PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2011Science604 citationsOpen Access

Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure

View Full Paper

Why the study?

Does a small molecule cardiac myosin activator improve cardiac function in systolic heart failure?

Population

Systolic Heart Failure

Design

Preclinical

Authors

FMFady I. MalikJHJames J. HartmanKEKathleen A. Elias

Discussion

Loading...

Member takes

Overview

Does not support clinical use of myosin activators; leaves open translation to systolic HF trials.

Structured PICO

Does a small molecule cardiac myosin activator improve cardiac function in systolic heart failure?

P
Population
Systolic Heart Failure
I
Intervention
Small molecule cardiac myosin activator
O
Outcome
Cardiac functionsurrogate

Cardiac myosin activation via a small molecule represents a potential therapeutic approach to improve cardiac function in systolic heart failure.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Malik et al. (2011) studied this question.

synapsesocial.com/papers/6995afcb206d9796cebc4ed9https://doi.org/10.1126/science.1200113
Ask AI
Helpful
Bookmark
Share
View Full Paper